Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 2004;97(Suppl 44):26–35.

Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?

Lee Dobson 1, Christopher D Sheldon 1, Andrew T Hattersley 1
PMCID: PMC1308796  PMID: 15239291

Abstract

The limited available evidence supports the use of insulin treatment in CFRD. This fits with the dominant problem in CFRD being insulin deficiency and progressive beta cell dysfunction, making tablets that stimulate the beta cell unlikely to be a successful strategy. It is possible that patients with IGT or CFRD with moderate hyperglycaemia (e.g. relative preservation of fasting glucose) may initially respond to beta cell secretagogues. A large randomized prospective trial in the USA should answer this point in the next few years.

Full Text

The Full Text of this article is available as a PDF (154.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdul-Karim F. W., Dahms B. B., Velasco M. E., Rodman H. M. Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch Pathol Lab Med. 1986 Jul;110(7):602–606. [PubMed] [Google Scholar]
  2. Ahmad T., Nelson R., Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism. 1994 Feb;43(2):163–167. doi: 10.1016/0026-0495(94)90239-9. [DOI] [PubMed] [Google Scholar]
  3. Allen H. F., Gay E. C., Klingensmith G. J., Hamman R. F. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S. Diabetes Care. 1998 Jun;21(6):943–948. doi: 10.2337/diacare.21.6.943. [DOI] [PubMed] [Google Scholar]
  4. Allen J. L. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med. 1986 Sep 18;315(12):764–764. doi: 10.1056/NEJM198609183151215. [DOI] [PubMed] [Google Scholar]
  5. Austin A., Kalhan S. C., Orenstein D., Nixon P., Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab. 1994 Jul;79(1):80–85. doi: 10.1210/jcem.79.1.8027259. [DOI] [PubMed] [Google Scholar]
  6. Bantle J. P., Thomas W. Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid. J Lab Clin Med. 1997 Oct;130(4):436–441. doi: 10.1016/s0022-2143(97)90044-5. [DOI] [PubMed] [Google Scholar]
  7. Boland E., Monsod T., Delucia M., Brandt C. A., Fernando S., Tamborlane W. V. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001 Nov;24(11):1858–1862. doi: 10.2337/diacare.24.11.1858. [DOI] [PubMed] [Google Scholar]
  8. Chazan B. I., Balodimos M. C., Holsclaw D. S., Shwachman H. Microcirculation in young adults with cystic fibrosis: retinal and conjunctival vascular changes in relation to diabetes. J Pediatr. 1970 Jul;77(1):86–92. doi: 10.1016/s0022-3476(70)80048-8. [DOI] [PubMed] [Google Scholar]
  9. Couce M., O'Brien T. D., Moran A., Roche P. C., Butler P. C. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab. 1996 Mar;81(3):1267–1272. doi: 10.1210/jcem.81.3.8772610. [DOI] [PubMed] [Google Scholar]
  10. Cucinotta D., Conti Nibali S., Arrigo T., Di Benedetto A., Magazzù G., Di Cesare E., Costantino A., Pezzino V., De Luca F. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res. 1990;34(1):33–38. doi: 10.1159/000181792. [DOI] [PubMed] [Google Scholar]
  11. Cucinotta D., De Luca F., Arrigo T., Di Benedetto A., Sferlazzas C., Gigante A., Rigoli L., Magazzù G. First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J Pediatr Endocrinol. 1994 Jan-Mar;7(1):13–17. doi: 10.1515/jpem.1994.7.1.13. [DOI] [PubMed] [Google Scholar]
  12. Cucinotta D., De Luca F., Gigante A., Arrigo T., Di Benedetto A., Tedeschi A., Lombardo F., Romano G., Sferlazzas C. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol. 1994 Mar;130(3):253–258. doi: 10.1530/eje.0.1300253. [DOI] [PubMed] [Google Scholar]
  13. Culler F. L., McKean L. P., Buchanan C. N., Caplan D. B., Meacham L. R. Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance. J Pediatr Gastroenterol Nutr. 1994 Apr;18(3):375–378. doi: 10.1097/00005176-199404000-00021. [DOI] [PubMed] [Google Scholar]
  14. De Schepper J., Hachimi-Idrissi S., Smitz J., Dab I., Loeb H. First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm Res. 1992;38(5-6):260–263. doi: 10.1159/000182555. [DOI] [PubMed] [Google Scholar]
  15. Dobson L., Hattersley A. T., Tiley S., Elworthy S., Oades P. J., Sheldon C. D. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child. 2002 Nov;87(5):430–431. doi: 10.1136/adc.87.5.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dobson Lee, Sheldon Christopher D., Hattersley Andrew T. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care. 2003 Jun;26(6):1940–1941. doi: 10.2337/diacare.26.6.1940-a. [DOI] [PubMed] [Google Scholar]
  17. Dodge J. A., Morison S., Lewis P. A., Coles E. C., Geddes D., Russell G., Littlewood J. M., Scott M. T. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child. 1997 Dec;77(6):493–496. doi: 10.1136/adc.77.6.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dolan T. F., Jr Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med. 1986 Apr 10;314(15):991–992. doi: 10.1056/NEJM198604103141514. [DOI] [PubMed] [Google Scholar]
  19. Finkelstein S. M., Wielinski C. L., Elliott G. R., Warwick W. J., Barbosa J., Wu S. C., Klein D. J. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988 Mar;112(3):373–377. doi: 10.1016/s0022-3476(88)80315-9. [DOI] [PubMed] [Google Scholar]
  20. Frase L. L., Strickland A. D., Kachel G. W., Krejs G. J. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology. 1985 Feb;88(2):478–484. doi: 10.1016/0016-5085(85)90510-4. [DOI] [PubMed] [Google Scholar]
  21. Garagorri J. M., Rodríguez G., Ros L., Sánchez A. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab. 2001 Jan;14(1):53–60. doi: 10.1515/jpem.2001.14.1.53. [DOI] [PubMed] [Google Scholar]
  22. Gross T. M., Mastrototaro J. J. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther. 2000;2 (Suppl 1):S19–S26. doi: 10.1089/15209150050214087. [DOI] [PubMed] [Google Scholar]
  23. Hamdi I., Green M., Shneerson J. M., Palmer C. R., Hales C. N. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Clin Endocrinol (Oxf) 1993 Jul;39(1):21–26. doi: 10.1111/j.1365-2265.1993.tb01746.x. [DOI] [PubMed] [Google Scholar]
  24. Handwerger S., Roth J., Gorden P., Di Sant' Agnese P., Carpenter D. F., Peter G. Glucose intolerance in cystic fibrosis. N Engl J Med. 1969 Aug 28;281(9):451–461. doi: 10.1056/NEJM196908282810901. [DOI] [PubMed] [Google Scholar]
  25. Hardin D. S., Moran A. Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin North Am. 1999 Dec;28(4):787-800, ix. doi: 10.1016/s0889-8529(05)70102-x. [DOI] [PubMed] [Google Scholar]
  26. Hinds A., Sheehan A. G., Parsons H. G. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance. Metabolism. 1995 Jan;44(1):13–18. doi: 10.1016/0026-0495(95)90283-x. [DOI] [PubMed] [Google Scholar]
  27. Holl R. W., Buck C., Cario H., Wolf A., Thon A., Kohne E., Debatin K. M. Diagnosis of diabetes in cystic fibrosis and thalassemia major. Diabetes Care. 1998 Apr;21(4):671–672. doi: 10.2337/diacare.21.4.671. [DOI] [PubMed] [Google Scholar]
  28. Iannucci A., Mukai K., Johnson D., Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol. 1984 Mar;15(3):278–284. doi: 10.1016/s0046-8177(84)80191-4. [DOI] [PubMed] [Google Scholar]
  29. Kentrup H., Bongers H., Spengler M., Kusenbach G., Skopnik H. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr. 1999 Jun;158(6):455–459. doi: 10.1007/s004310051119. [DOI] [PubMed] [Google Scholar]
  30. Kopito L. E., Shwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res. 1976 Aug;10(8):742–749. doi: 10.1203/00006450-197608000-00010. [DOI] [PubMed] [Google Scholar]
  31. Lanng S., Hansen A., Thorsteinsson B., Nerup J., Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ. 1995 Sep 9;311(7006):655–659. doi: 10.1136/bmj.311.7006.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiøtz P. O., Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994 Jan;83(1):72–77. doi: 10.1111/j.1651-2227.1994.tb12956.x. [DOI] [PubMed] [Google Scholar]
  33. Lanng S., Thorsteinsson B., Nerup J., Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 1994 Aug;83(8):849–853. doi: 10.1111/j.1651-2227.1994.tb13156.x. [DOI] [PubMed] [Google Scholar]
  34. Lanng S., Thorsteinsson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992 Sep;151(9):684–687. doi: 10.1007/BF01957574. [DOI] [PubMed] [Google Scholar]
  35. Lanng S., Thorsteinsson B., Røder M. E., Nerup J., Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf) 1994 Aug;41(2):217–223. doi: 10.1111/j.1365-2265.1994.tb02533.x. [DOI] [PubMed] [Google Scholar]
  36. Lanng S., Thorsteinsson B., Røder M. E., Orskov C., Holst J. J., Nerup J., Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993 Mar;128(3):207–214. doi: 10.1530/acta.0.1280207. [DOI] [PubMed] [Google Scholar]
  37. Lippe B. M., Sperling M. A., Dooley R. R. Pancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr. 1977 May;90(5):751–755. doi: 10.1016/s0022-3476(77)81241-9. [DOI] [PubMed] [Google Scholar]
  38. Löhr M., Goertchen P., Nizze H., Gould N. S., Gould V. E., Oberholzer M., Heitz P. U., Klöppel G. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol. 1989;414(2):179–185. doi: 10.1007/BF00718598. [DOI] [PubMed] [Google Scholar]
  39. Mastrototaro J. J. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther. 2000;2 (Suppl 1):S13–S18. doi: 10.1089/15209150050214078. [DOI] [PubMed] [Google Scholar]
  40. Milla C. E., Warwick W. J., Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):891–895. doi: 10.1164/ajrccm.162.3.9904075. [DOI] [PubMed] [Google Scholar]
  41. Miller M., Ward L., Thomas B. J., Cooksley W. G., Shepherd R. W. Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis. Am J Clin Nutr. 1982 Sep;36(3):492–499. doi: 10.1093/ajcn/36.3.492. [DOI] [PubMed] [Google Scholar]
  42. Moran A., Diem P., Klein D. J., Levitt M. D., Robertson R. P. Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991 May;118(5):715–723. doi: 10.1016/s0022-3476(05)80032-0. [DOI] [PubMed] [Google Scholar]
  43. Moran A., Hardin D., Rodman D., Allen H. F., Beall R. J., Borowitz D., Brunzell C., Campbell P. W., 3rd, Chesrown S. E., Duchow C. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract. 1999 Aug;45(1):61–73. doi: 10.1016/s0168-8227(99)00058-3. [DOI] [PubMed] [Google Scholar]
  44. Moran A., Milla C., Ducret R., Nair K. S. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes. 2001 Jun;50(6):1336–1343. doi: 10.2337/diabetes.50.6.1336. [DOI] [PubMed] [Google Scholar]
  45. Moran A., Phillips J., Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care. 2001 Oct;24(10):1706–1710. doi: 10.2337/diacare.24.10.1706. [DOI] [PubMed] [Google Scholar]
  46. Moran A., Pyzdrowski K. L., Weinreb J., Kahn B. B., Smith S. A., Adams K. S., Seaquist E. R. Insulin sensitivity in cystic fibrosis. Diabetes. 1994 Aug;43(8):1020–1026. doi: 10.2337/diab.43.8.1020. [DOI] [PubMed] [Google Scholar]
  47. Nousia-Arvanitakis S., Galli-Tsinopoulou A., Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr. 2001 May;90(5):515–519. [PubMed] [Google Scholar]
  48. Pickup J. C., Shaw G. W., Claremont D. J. In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer. Diabetologia. 1989 Mar;32(3):213–217. doi: 10.1007/BF00265097. [DOI] [PubMed] [Google Scholar]
  49. ROSAN R. C., SHWACHMAN H., KULCZVCKI L. I. Diabetes mellitus and cystic fibrosis of the pancreas. Laboratory and clinical observations. Am J Dis Child. 1962 Dec;104:625–634. doi: 10.1001/archpedi.1962.02080030625007. [DOI] [PubMed] [Google Scholar]
  50. Redmond A. O., Buchanan K. D., Trimble E. R. Insulin and glucagon response to arginine infusion in cystic fibrosis. Acta Paediatr Scand. 1977 Mar;66(2):199–204. doi: 10.1111/j.1651-2227.1977.tb07833.x. [DOI] [PubMed] [Google Scholar]
  51. Reisman J., Corey M., Canny G., Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics. 1990 Sep;86(3):374–377. [PubMed] [Google Scholar]
  52. Rodman H. M., Doershuk C. F., Roland J. M. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine (Baltimore) 1986 Nov;65(6):389–397. doi: 10.1097/00005792-198611000-00004. [DOI] [PubMed] [Google Scholar]
  53. Rolon M. A., Benali K., Munck A., Navarro J., Clement A., Tubiana-Rufi N., Czernichow P., Polak M. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr. 2001 Aug;90(8):860–867. [PubMed] [Google Scholar]
  54. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  55. Rosenecker J., Eichler I., Bärmeier H., von der Hardt H. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol. 2001 Nov;32(5):351–355. doi: 10.1002/ppul.1143. [DOI] [PubMed] [Google Scholar]
  56. Rosenecker J., Höfler R., Steinkamp G., Eichler I., Smaczny C., Ballmann M., Posselt H. G., Bargon J., von der Hardt H. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res. 2001 Aug 27;6(8):345–350. [PubMed] [Google Scholar]
  57. SHWACHMAN H., LEUBNER H., CATZEL P. Mucoviscidosis. Adv Pediatr. 1955;7:249–323. [PubMed] [Google Scholar]
  58. Sheppard D. N., Welsh M. J. Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol. 1992 Oct;100(4):573–591. doi: 10.1085/jgp.100.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Soejima K., Landing B. H. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol. 1986;6(1):25–46. doi: 10.3109/15513818609025923. [DOI] [PubMed] [Google Scholar]
  60. Stutchfield P. R., O'Halloran S., Teale J. D., Isherwood D., Smith C. S., Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child. 1987 Aug;62(8):805–810. doi: 10.1136/adc.62.8.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sullivan M. M., Denning C. R. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics. 1989 Oct;84(4):642–647. [PubMed] [Google Scholar]
  62. Taylor C. J., Baxter P. S., Hardcastle J., Hardcastle P. T., Goldhill J. Glucose intolerance in cystic fibrosis. Arch Dis Child. 1989 May;64(5):759–759. doi: 10.1136/adc.64.5.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wilmshurst E. G., Soeldner J. S., Holsclaw D. S., Kaufmann R. L., Shwachman H., Aoki T. T., Gleason R. E. Endogenous and exogenous insulin responses in patients with cystic fibrosis. Pediatrics. 1975 Jan;55(1):75–82. [PubMed] [Google Scholar]
  64. Yung B., Hodson M. E. Diabetes in cystic fibrosis. J R Soc Med. 1999;92 (Suppl 37):35–40. doi: 10.1177/014107689909237s07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Yung B., Kemp M., Hooper J., Hodson M. E. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax. 1999 Jan;54(1):40–43. doi: 10.1136/thx.54.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Yung B., Noormohamed F. H., Kemp M., Hooper J., Lant A. F., Hodson M. E. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med. 2002 Mar;19(3):221–226. doi: 10.1046/j.1464-5491.2002.00666.x. [DOI] [PubMed] [Google Scholar]
  67. Zipf W. B., Kien C. L., Horswill C. A., McCoy K. S., O'Dorisio T., Pinyerd B. L. Effects of tolbutamide on growth and body composition of nondiabetic children with cystic fibrosis. Pediatr Res. 1991 Oct;30(4):309–314. doi: 10.1203/00006450-199110000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES